Search for: "Dr. Reddy" Results 261 - 280 of 395
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2015, 1:55 am
  Indeed, the cross-undertaking was ultimately granted in favour of the Actavis group, the Teva group and Dr Reddy’s Laboratories, in addition to the public bodies. [read post]
18 Mar 2021, 4:00 am by Brian
Generic drug manufacturers like Glaxo-Smith-Kline and Dr. [read post]
25 Mar 2007, 9:46 pm
Curiously, statements made by Pfizer in the Dr. [read post]
23 Jun 2010, 10:28 pm
Reddy's over generic Allegra (Patent Docs) Combigan (Brimonidine) – US: Patent infringement complaint following a Para IV certification: Allergan, Inc. v. [read post]
12 Oct 2010, 8:56 pm by Kelly
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic… [read post]
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog)   General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) US: Blinded… [read post]
24 Dec 2009, 12:08 pm by D. Daniel Sokol
Sudhakara Reddy of Indira Gandhi Institute of Development Research; Professor Fu Jun of Peking University; Professor Sun Shihai of Chinese Academy of Social Sciences; Dr John Alexander Michael of University of Madras; Professor Sheng Kaiyan of Shanghai Academy of Social Sciences; Professor Guo Sujian of Fudan University; Professor Dilip K. [read post]
18 Mar 2021, 4:00 am by Brian
Generic drug manufacturers like Glaxo-Smith-Kline and Dr. [read post]
27 Apr 2011, 4:55 am by Marie Louise
Reddy’s (GenericsWeb) Zyprexa (Olanzapine) – Spain: Ranbaxy launches generic Olanzapine tablets, in Spain, on day-1 following patent expiry (GenericsWeb) [read post]
26 May 2010, 4:00 pm by Heather Young
 PHS' hospitals provided more than $120 Million in charity care to the uninsured and indigent in 2009 and PHS' founder, Dr. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) US: Obvious-type double… [read post]